MedPath

Transplantation of cultured melanocyte from plucked hair in vitiligo

Phase 4
Not yet recruiting
Conditions
Vitiligo
Registration Number
CTRI/2017/03/008186
Lead Sponsor
AIIMS
Brief Summary

Vitiligo is a common acquired depigmenting disorder with significant psychological distress. Surgical treatment is indicated for depigmented areas not responding to medical treatment in stable disease. When large surface area needs to be covered we need more no. of melanocytes. So melanocyte culture is an important modality to provide this motive. If we are able to culture melanocytes from a renewable source like plucked hair follicle it can be a major breakthrough in vitiligo research and treatment. In this study, we will try to culture melanocyte from plucked hair follicle and transplant in to patients vitiligo lesion. As a pilot study we kept sample size of 5 patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Patients with clinical diagnosis of segmental or generalized vitiligo 2.
  • Vitiligo should have been stable for at least two year or more to be included in the study.
  • The patient should have at least one large patch of 16 cm2 or more will be taken.
Exclusion Criteria

1.Age less than 18yrs 2.Pregnancy 3.Koebnerization 4.Keloid or bleeding diathesis 5.Active infection at the site 6.Other autoimmune diseases 7.Inability to come for follow-up for at least 6 months 8.Patients with involvement of only acral sites and bony prominences.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RepigmentationRepigmentation:4,8,12,16,20,24 weeks
Secondary Outcome Measures
NameTimeMethod
Patient’s satisfaction about the procedure6 months

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

South, DELHI, India

All India Institute of Medical Sciences
🇮🇳South, DELHI, India
Maninder Kaur
Principal investigator
8860118442
manu31aug@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.